Open an account

Medavail Holdings

MDVLQ · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About MDVLQ

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. The company is headquartered in Phoenix, Arizona and currently employs 279 full-time employees. The company went IPO on 2008-10-20. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.

Employees
279
Headquarters
Phoenix, Arizona
Listed
Oct 20, 2008
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Website
investors.medavail.com

MDVLQ key statistics

Market cap
161
Price-earnings ratio
0.00
Dividend yield
—
Average volume
100
Volume
4
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.05
52 Week low
$0.00

Medavail Holdings (MDVLQ) at a glance

As of Oct 20, 2026, Medavail Holdings (MDVLQ) shares are priced at $0.0001, giving the company a market cap of 161 and a price-to-earnings ratio of 0.00.

Volume so far is 4 shares, below the average of 100 shares a day.

Over the past year Medavail Holdings has ranged from $0.00 to $0.05, and now sits 0% of the way up that range.

Medavail Holdings met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q1 FY23 it reported -$11.00 per share against an estimate of -$10.81.

MDVLQ earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 17.6% on average.

  1. Q2 FY21: reported -$16.00 per share against an estimate of -$15.45
  2. Q3 FY21: reported -$17.00 per share against an estimate of -$16.74
  3. Q4 FY21: reported -$19.00 per share against an estimate of -$18.28
  4. Q1 FY22: reported -$20.00 per share against an estimate of -$18.54
  5. Q2 FY22: reported -$8.50 per share against an estimate of -$13.65
  6. Q3 FY22: reported -$7.50 per share against an estimate of -$7.72
  7. Q4 FY22: reported -$7.00 per share against an estimate of -$7.98
  8. Q1 FY23: reported -$11.00 per share against an estimate of -$10.81

Similar companies

Companies in the same industry as Medavail Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.